The GH Resistance of Liver Cirrhosis Improved by Rgh Therapy.

Xiaokui Guo
2004-01-01
Abstract:To evaluate the effect of recombined human growth hormone therapy on the GH resistance state of liver cirrhosis with different Child-Pugh score and on their low serum albumen state. 51 patients were divided into two groups, including Child-pugh 5-8, 25 cases and Child-Pugh 9-15, 26 cases. Cases were further divided into treatment group (treated with rGH) and control group (The treated with human blood albumen) according to randonized block design for 10 days. Plasma GH, IGF-1 were measured by RIA before treatment, 24h after treatment and the end of treatment, respectively. GH level in liver cirrhosis is higher than that in health (P0.05),but IGF-1 level decrease obviously (P0.01). The GH resistance of liver cirrhosis was improved by rGH therapy. At the end of treatment, GH level of liver cirrhosis in Child-Pugh 9-15 is higher than that in Child-Pugh 5-8 (9.91±7.61 vs 4.75±3.94,μg/L,P0.05),contrarily,IGF-1 level is less(48.43±16.88 vs 63.47±22.19,μg/L,P0.05).Low ALB level in liver cirrhosis were improved by rGH therapy. The GH resistance in liver cirrhosis, especially low Child-Pugh score cirrhosis, and their low albumen state can be improved by rGH therapy.
What problem does this paper attempt to address?